Medical Device Regulation in Spain
Spain regulates medical devices under the EU Medical Device Regulation (EU MDR 2017/745). The Spanish Agency of Medicines and Medical Devices (AEMPS) is the national competent authority. Spain has a large and diverse medical device market and actively participates in EU-wide regulatory coordination and market surveillance activities.
Recent Regulatory Updates
Showing the latest 3 updates. Sign up to see more
Common specs for non-medical products under MDR
Updates transitional rules for Annex XVI products
MDR/IVDR changes: Eudamed, supply, IVD transition.
Sources Tracked by Qalico
Qalico continuously monitors 19 references across guidelines, regulations, and standards for Spain.
Regulations
Device Classification
Spain applies the EU MDR classification system. Class I devices are low risk (e.g., elastic bandages, corrective spectacles). Class IIa devices are low-moderate risk (e.g., contact lenses, dental crowns). Class IIb devices are moderate-high risk (e.g., intensive care ventilators, X-ray equipment). Class III devices are high risk (e.g., cardiac pacemakers, absorbable sutures). Classification follows EU MDR Annex VIII rules.
Official classification guidance →Official Guidance Documents
Official AEMPS portal for medical device regulation in Spain, including guidance documents, registration procedures, and vigilance requirements.
Information on Spain's medical device vigilance system for reporting incidents and field safety corrective actions.
European database for medical device registration, UDI, and certificate management.
Standards & Key Principles
Applicable Standards
Key Principles
- Medical devices must bear the CE mark under EU MDR 2017/745 to be legally marketed in Spain.
- EUDAMED registration and UDI compliance are mandatory.
- Notified body involvement is required for Class IIa, IIb, and III devices.
- Non-EU manufacturers must designate an EU-based authorized representative.
- AEMPS maintains a national registry of medical devices in addition to EUDAMED.
- Post-market surveillance and vigilance reporting to AEMPS are mandatory.
Pre-Market Requirements
Compliance with EU MDR 2017/745 and CE marking are required. A notified body must be involved for Class IIa, IIb, and III devices.
Technical documentation per EU MDR Annexes II and III must be compiled, including design documentation, risk management files, and clinical data.
Clinical evaluations are required for all device classes under EU MDR Article 61. Clinical investigations require AEMPS authorization and ethics committee approval.
In addition to EUDAMED, devices must be registered in AEMPS's national database. Importers and distributors in Spain have specific registration obligations.
Post-Market Requirements
A PMS system per EU MDR is required. PSURs are required for Class IIa, IIb, and III devices.
Serious incidents must be reported to AEMPS within EU MDR-mandated timelines. FSCAs and FSNs must be communicated and coordinated with AEMPS.
Ongoing PMCF activities are required to validate continued clinical safety and performance of marketed devices.
International Recognition & Reliance
CE-marked devices under EU MDR are recognized across all EU/EEA member states.
CE-marked devices from EU member states are recognized in Switzerland under the MRA framework.